Literature DB >> 2481441

Characterization and use of the potent ribonuclease inhibitor aurintricarboxylic acid for the isolation of RNA from animal tissues.

A F Skidmore1, T J Beebee.   

Abstract

Inclusion of aurintricarboxylic acid (ATA) in extraction buffers for the isolation of RNA from animal tissues resulted in high yields (0.5-2.0 mg/g of tissue) of undegraded material as judged by agarose-gel-electrophoretic analyses and Northern-blotting experiments. However, ATA bound to nucleic acids, forming stable complexes, and so we have established methods for spectrophotometric quantification of RNA in these coloured complexes, and for easy removal of sufficient ATA to leave RNA in a consistently hybridizable condition at the end of a purification. The use and subsequent removal of ATA was straightforward and gave satisfactory results for all rat tissues tested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481441      PMCID: PMC1133392          DOI: 10.1042/bj2630073

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  Fractionation and structural elucidation of the active components of aurintricarboxylic acid, a potent inhibitor of protein nucleic acid interactions.

Authors:  R G González; B J Blackburn; T Schleich
Journal:  Biochim Biophys Acta       Date:  1979-05-24

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

Review 3.  Hybridization of nucleic acids immobilized on solid supports.

Authors:  J Meinkoth; G Wahl
Journal:  Anal Biochem       Date:  1984-05-01       Impact factor: 3.365

4.  Hybridization of denatured RNA transferred or dotted nitrocellulose paper.

Authors:  P S Thomas
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

5.  Inhibition of nuclear ribonuclease activity during transcription in vitro by aurintricarboxylic acid and vanadyl riboncleoside complexes.

Authors:  B Schulz-Harder; J R Tata
Journal:  Biochem Biophys Res Commun       Date:  1982-02-11       Impact factor: 3.575

6.  "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

7.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

8.  Mechanism of action of polymeric aurintricarboxylic acid, a potent inhibitor of protein--nucleic acid interactions.

Authors:  R G González; R S Haxo; T Schleich
Journal:  Biochemistry       Date:  1980-09-02       Impact factor: 3.162

9.  Use of aurintricarboxylic acid as an inhibitor of nucleases during nucleic acid isolation.

Authors:  R B Hallick; B K Chelm; P W Gray; E M Orozco
Journal:  Nucleic Acids Res       Date:  1977-09       Impact factor: 16.971

10.  Cyclic AMP regulation of lactate dehydrogenase. Quantitation of lactate dehydrogenase M-subunit messenger RNA in isoproterenol-and N6,O2'-dibutyryl cyclic AMP-stimulated rat C6 glioma cells by hybridization analysis using a cloned cDNA probe.

Authors:  M F Miles; P Hung; R A Jungmann
Journal:  J Biol Chem       Date:  1981-12-10       Impact factor: 5.157

  10 in total
  9 in total

1.  Heterologous expression of a mammalian ABC transporter in plant and its application to phytoremediation.

Authors:  Kazufumi Yazaki; Nao Yamanaka; Tsugumi Masuno; Satoshi Konagai; Nobukazu Shitan; Shuji Kaneko; Kazumitsu Ueda; Fumihiko Sato
Journal:  Plant Mol Biol       Date:  2006-06       Impact factor: 4.076

2.  Naturally occurring polyphenol, morin hydrate, inhibits enzymatic activity of N-methylpurine DNA glycosylase, a DNA repair enzyme with various roles in human disease.

Authors:  Monica Dixon; Jordan Woodrick; Suhani Gupta; Soumendra Krishna Karmahapatra; Stephen Devito; Sona Vasudevan; Sivanesan Dakshanamurthy; Sanjay Adhikari; Venkata M Yenugonda; Rabindra Roy
Journal:  Bioorg Med Chem       Date:  2015-01-17       Impact factor: 3.641

3.  EST analysis of hop glandular trichomes identifies an O-methyltransferase that catalyzes the biosynthesis of xanthohumol.

Authors:  Jana Nagel; Lana K Culley; Yuping Lu; Enwu Liu; Paul D Matthews; Jan F Stevens; Jonathan E Page
Journal:  Plant Cell       Date:  2008-01-25       Impact factor: 11.277

4.  Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology.

Authors:  Emmanuel Sturchler; Weimin Chen; Timothy Spicer; Peter Hodder; Patricia McDonald; Derek Duckett
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

5.  Aurintricarboxylic acid modulates the affinity of hepatitis C virus NS3 helicase for both nucleic acid and ATP.

Authors:  William R Shadrick; Sourav Mukherjee; Alicia M Hanson; Noreena L Sweeney; David N Frick
Journal:  Biochemistry       Date:  2013-08-26       Impact factor: 3.162

6.  RNA Extraction from Animal and Human's Cancerous Tissues: Does Tissue Matter?

Authors:  Ali Akbar Samadani; Novin Nikbakhsh; Sadegh Fattahi; Roghayeh Pourbagher; Seyyed Mohsen Aghajanpour Mir; Narges Mousavi Kani; Zeinab Abedian; Haleh Akhavan-Niaki
Journal:  Int J Mol Cell Med       Date:  2015

7.  Optimization of RNA extraction from rat pancreatic tissue.

Authors:  Sanaz Dastgheib; Cambyz Irajie; Raheleh Assaei; Farhad Koohpeima; Pooneh Mokarram
Journal:  Iran J Med Sci       Date:  2014-05

8.  Polyvinylsulfonic acid: A Low-cost RNase inhibitor for enhanced RNA preservation and cell-free protein translation.

Authors:  Conner C Earl; Mark T Smith; Richard A Lease; Bradley C Bundy
Journal:  Bioengineered       Date:  2017-06-29       Impact factor: 3.269

9.  Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancer.

Authors:  Nadiya Druzhyna; Bartosz Szczesny; Gabor Olah; Katalin Módis; Antonia Asimakopoulou; Athanasia Pavlidou; Petra Szoleczky; Domokos Gerö; Kazunori Yanagi; Gabor Törö; Isabel López-García; Vassilios Myrianthopoulos; Emmanuel Mikros; John R Zatarain; Celia Chao; Andreas Papapetropoulos; Mark R Hellmich; Csaba Szabo
Journal:  Pharmacol Res       Date:  2016-08-10       Impact factor: 7.658

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.